Doebele Robert 4
4 · Rain Oncology Inc. · Filed Aug 11, 2023
Insider Transaction Report
Form 4
Doebele Robert
EVP, Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-09+99,400→ 99,400 totalExercise: $1.21Exp: 2033-08-09→ Common Stock (99,400 underlying) - Award
Stock Option (Right to Buy)
2023-08-09+49,700→ 49,700 totalExercise: $1.21Exp: 2033-08-09→ Common Stock (49,700 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 99,400 shares of the Issuer's common stock, which will vest in equal installments on May 9, 2024 and February 9, 2025, subject to the Reporting Person's continued service to the Issuer.
- [F2]This option represents a right to purchase a total of 49,700 shares of the Issuer's common stock, which will vest in equal installments on May 9, 2024 and February 9, 2025, subject to the achievement of certain corporate goals and the Reporting Person's continued service to the Issuer.